首页> 外文期刊>Endocrine Connections >Baseline MRI findings as predictors of hypopituitarism in patients with non-functioning pituitary adenomas
【24h】

Baseline MRI findings as predictors of hypopituitarism in patients with non-functioning pituitary adenomas

机译:基线MRI调查结果作为非功能性垂体腺瘤患者低钠素化的预测因子

获取原文
           

摘要

Hypopituitarism tends to occur in large pituitary adenomas. However, similar tumors could present with strikingly different hormonal deficiencies. In this study, we looked at MRI characteristics in non-functioning pituitary adenomas (NFPA), which could predict secondary adrenal insufficiency (SAI) and central hypothyroidism (CHT). We reviewed the files of patients with NFPA attending our clinic. Tumor size, invasiveness, MR-signal intensity, and gadolinium enhancement in preoperative MRI were recorded along with documented presurgical hypopituitarism profile. Logistic regression was used to predict SAI, CHT, or both (SAI/CHT) based on MRI and demographic parameters. Receiver operating characteristic curves were used to determine their diagnostic utility. One hundred twenty-one patients were included in the study. Older age ( P?=? 0.021), male sex ( P?=? 0.043), stalk deviation ( P & 0.0001), contrast enhancement ( P?=? 0.029), and optic chiasma compression ( P?=? 0.012) were associated with SAI/CHT. Adenoma vertical height, largest diameter, and estimated volume were also strongly associated with SAI/CHT ( P & 0.0001). These associations remained significant in a multivariate analysis. No tumor smaller than 12 mm in vertical height, 17 mm in largest diameter, or 0.9 cm ~(3) in volume was associated with SAI/CHT. At cut-off ≥18 mm for vertical height, ≥23 mm for largest diameter, and ≥3.2 cm ~(3) the sensitivity was around 90–92% for detecting SAI/CHT. Only vertical height was significantly associated with any one or more pituitary hormonal deficit ( P?=? 0.001). In conclusion, adenoma size, independent of the measurement used, remains the best predictor of SAI/CHT in NFPA. Dynamic testing to rule out SAI is probably indicated in adenomas larger than 18 mm vertical height, 23 mm largest diameter and 3.2 cm ~(3) adenoma volume.
机译:低垂体主义倾向于发生大脑垂体腺瘤。然而,类似的肿瘤可能出现惊人的荷尔蒙缺陷。在这项研究中,我们研究了非功能性垂体腺瘤(NFPA)中的MRI特征,其可以预测二次肾上腺素不足(SAI)和中央甲状腺功能亢进(CHT)。我们审查了NFPA患者的档案,参加了我们的诊所。术前MRI中的肿瘤大小,侵袭性,MR信号强度和钆增强以及记录的前型低次缺失性剖面。 Logistic回归用于根据MRI和人口统计参数来预测SAI,CHT或两者(SAI / CHT)。接收器操作特征曲线用于确定其诊断效用。研究中包含一百二十一名患者。年龄较大的(p?= 0.021),男性性别(p?= 0.043),茎偏差(p& 0.0001),对比增强(p?= 0.029),和光学克拉夏压缩(p?=? 0.012)与SAI / CHT相关。腺瘤垂直高度,最大直径和估计的体积也与Sai / CHT(P& LT; 0.0001)密切相关。这些关联在多变量分析中保持重要意义。没有垂直高度小于12mm的肿瘤,最大直径为17毫米,或体积中的0.9cm〜(3)与Sai / Cht相关。在垂直高度的截止≥18mm时,最大直径≥23mm,≥3.2厘米〜(3)敏感性约为90-92%,检测SAI / CHT。只有垂直高度显着与任何一个或多个垂体荷尔蒙缺陷有关(P?= 0.001)。总之,腺瘤大小与所使用的测量无关,仍然是NFPA中SAI / CHT的最佳预测因子。排除SAI的动态测试可能在大于18 mm垂直高度,23mm最大直径和3.2cm〜(3)腺瘤体积中的腺瘤中表明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号